
GILEAD SCIENCES, INC. — Investor Relations & Filings
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops, and commercializes innovative medicines to address unmet medical needs. The company's primary focus is on virology, with a portfolio of transformative therapies for life-threatening diseases such as HIV/AIDS and viral hepatitis. Gilead is also expanding its impact in oncology and inflammation, maintaining a diverse pipeline of clinical programs across these key therapeutic areas. The company invests in scientific research to develop treatments for some of the world's most challenging diseases, aiming to improve the lives of patients globally.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| FORM 8-K | 2026-05-20 | English | |
| 424B5 | 2026-05-18 | English | |
| FWP | 2026-05-14 | English | |
| 424B5 | 2026-05-14 | English | |
| Regulatory Filings 2026 | 2026-05-08 | English | |
| S-8 - GILEAD SCIENCES, INC. (0000882095) (Filer) | 2026-05-07 | English |
Browse filings by year
17 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46691604 | FORM 8-K | 2026-05-20 | English | ||
| 46459832 | 424B5 | 2026-05-18 | English | ||
| 46273906 | FWP | 2026-05-14 | English | ||
| 46012309 | 424B5 | 2026-05-14 | English | ||
| 46151278 | Regulatory Filings 2026 | 2026-05-08 | English | ||
| 43582483 | S-8 - GILEAD SCIENCES, INC. (0000882095) (Filer) | 2026-05-07 | English | ||
| 43582866 | 10-Q - GILEAD SCIENCES, INC. (0000882095) (Filer) | 2026-05-07 | English | ||
| 43481120 | 8-K - GILEAD SCIENCES, INC. (0000882095) (Filer) | 2026-05-07 | English | ||
| 46151281 | FORM 8-K | 2026-05-04 | English | ||
| 46151286 | Major Shareholding Notification 2026 | 2026-04-30 | English | ||
| 46151283 | Major Shareholding Notification 2026 | 2026-04-28 | English | ||
| 38002356 | 8-K - GILEAD SCIENCES, INC. (0000882095) (Filer) | 2026-04-28 | English | ||
| 33065533 | 144 - GILEAD SCIENCES, INC. (0000882095) (Subject) | 2026-03-27 | English | ||
| 33053040 | SCHEDULE 13G/A - GILEAD SCIENCES, INC. (0000882095) (Subject) | 2026-03-26 | English | ||
| 33001942 | ARS - GILEAD SCIENCES, INC. (0000882095) (Filer) | 2026-03-20 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
JW PHARMACEUTICAL
Develops and commercializes pharmaceuticals, OTC solutions,…
|
001060 | KR | Manufacturing |
|
JW SHINYAK CORPORATION
Develops and sells medicines, specializing in dermatology a…
|
067290 | KR | Manufacturing |
|
Jyong Biotech Ltd.
Develops plant-derived drugs for urinary system diseases, w…
|
MENS | US | Manufacturing |
|
Kabra Drugs Ltd
Manufactures and distributes bulk drugs, intermediates, and…
|
524322 | IN | Manufacturing |
|
Kailera Therapeutics, Inc.
A clinical-stage biotech company advancing diverse injectab…
|
KLRA | US | Manufacturing |
|
kainos loboratories,inc
Develops and manufactures in-vitro diagnostics and clinical…
|
4556 | JP | Manufacturing |
|
Kaisa Health Group Holdings Limited
Investment holding focused on pharmaceuticals, dental devic…
|
876 | HK | Manufacturing |
|
KAKEN PHARMACEUTIAL CO., LTD.
Develops and markets pharmaceuticals for dermatology, ortho…
|
4521 | JP | Manufacturing |
|
KALA BIO, Inc.
Clinical-stage biopharma developing therapies for rare and …
|
KALA | US | Manufacturing |
|
Kalaris Therapeutics, Inc.
Clinical-stage biopharmaceutical company developing treatme…
|
KLRS | US | Manufacturing |
GILEAD SCIENCES, INC. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/29828/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=29828 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=29828 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=29828 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 29828}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for GILEAD SCIENCES, INC. (id: 29828)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.